adenov-m 1

1. Treatment outcomes for drug-resistant tuberculosis: a retrospective longitudinal study
2. Correction: Trends and disparities in tuberculosis burden in Kazakhstan and Mongolia (2017–2021): a comparative analysis using GBD metrics(Front. Public Health., (2025), 13, (1575107), 10.3389/fpubh.2025.1575107)
3. Trends and disparities in tuberculosis burden in Kazakhstan and Mongolia (2017–2021): a comparative analysis using GBD metrics
4. Perspectives on multisectoral accountability framework to end tuberculosis in the Eastern Europe and Central Asia region: a mixed-methods study
5. Safety of Treatment Regimens Containing Bedaquiline and Delamanid in the endTB Cohort
6. Effectiveness and safety of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis: a prospective cohort study
7. Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings
8. Impact of the COVID-19 pandemic on TB epidemiology
9. Epidemiology, detection, diagnosis and treatment of TB in children in Kazakhstan
10. Genetic diversity, drug resistance, and transmission patterns of tuberculosis based on whole-genome sequencing in Almaty, Kazakhstan
1